Future of melatonin as a therapeutic agent

Michal Karasek, Russel J. Reiter, Daniel P. Cardinali, Marek Pawlikowski

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Report of the round table conference summarizing the International Symposium on "Melatonin: Clinical Significance and Therapeutic Applications" is presented in this article. Some sleep disorders and circadian rhythm disturbances are the widely accepted indications for melatonin treatment. However, other possibilities for use of melatonin in the therapy should be also taken into account, including a co-treatment in cancer patients and free radical-related diseases. All aspects of the possible therapeutic use of melatonin as well as its safety, dosage, side effects and contraindications are discussed herein based on the round table conference and they are presented in this paper.

Original languageEnglish (US)
Pages (from-to)118-121
Number of pages4
JournalNeuroendocrinology Letters
Issue numberSUPPL. 1
StatePublished - May 21 2002
Externally publishedYes


  • Insomnia
  • Jet-lag
  • Melatonin
  • Therapeutic application

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems
  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Future of melatonin as a therapeutic agent'. Together they form a unique fingerprint.

Cite this